logo
Select company
Select metric
84.06%Return on Equity
VS
Market
98
Sector
99
Industry
100
History
80
$ 11.93Close
$ 10.13 - $ 21.29 52-Week Range
Ticker Information

Ticker

NRC

Company Name

NATIONAL RESEARCH CORP

Sector

Healthcare

Industry

Health Information Services

Exchange

NASDAQ

NATIONAL RESEARCH CORP - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRC - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 21.33M$ 17.93M84.06%
3/31/2025$ 29.67M$ 24.21M81.59%
12/31/2024$ 31.28M$ 24.78M79.22%
9/30/2024$ 34.62M$ 27.08M78.21%
6/30/2024$ 40.2M$ 29.27M72.81%
3/31/2024$ 36.95M$ 30.37M82.19%
12/31/2023$ 48.95M$ 30.97M63.26%
9/30/2023$ 57.87M$ 28.75M49.69%
6/30/2023$ 77.75M$ 29.18M37.53%
3/31/2023$ 74.67M$ 30.23M40.48%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NATIONAL RESEARCH CORP's latest trailing twelve months (TTM) ROE stands at 66.54%.
  • Over the past 5 years, NATIONAL RESEARCH CORP's average ROE has been 58.43%.
  • The median ROE for NATIONAL RESEARCH CORP during this period was 52.01%
  • NATIONAL RESEARCH CORP reached its highest ROE over the past 5 years at 84.06%.
  • The lowest ROE recorded by NATIONAL RESEARCH CORP in the same timeframe 37.53%

NATIONAL RESEARCH CORP's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
SPOK : SPOK HOLDINGS INC 11.3%OPRX : OPTIMIZERX CORP -8.27%CTMX : CYTOMX THERAPEUTICS INC 40.02%TALK : TALKSPACE INC 2.54%SLP : SIMULATIONS PLUS INC -51.05%RXST : RXSIGHT INC -11.6%PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -856.02%AIRS : AIRSCULPT TECHNOLOGIES INC -15.92%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -26.04%LFCR : LIFECORE BIOMEDICAL INC -3320.28%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for NATIONAL RESEARCH CORP is calculated as follows: Net Inc. Cmn. [ $ 37.75M ] / Equity [ $ 56.73M ]
(=) ROE [ 66.54% ]

NRC - Return on Equity, Last 5 years

37.53%

Minimum

Jun 30, 2023

84.06%

Maximum

Jun 30, 2025

58.43%

Average

52.01%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%